- advertising -

AmelioSense calms pyroptosis, soothes irritated skin

"Our latest ingredient AmelioSense presents a revolutionary approach to treating skin irritation and redness. AmelioSense acts effectively against pyroptosis, a highly inflammatory programmed cell death, while reducing the general skin inflammation processes that lead to redness and irritated skin."says Mibelle Biochemistry.

Mibelle Biochemistry points out that recent studies have identified pyroptosis as a key factor exacerbating rosacea. This process involves activation of the inflammasome, leading to chronic inflammation and worsening of symptoms.

AmelioSense inhibits active caspase-1, the main enzyme responsible for pyroptosis, and reduces the expression of inflammatory markers. According to Mibelle Biochemistry, clinical studies have shown that AmelioSense visibly reduces the appearance of blood vessels and redness, particularly in the cheek area, offering relief and improved skin appearance for people affected by rosacea and other inflammatory skin conditions. 

To combat pyroptosis, AmelioSense combines shepherd's purse extract with a powerful liposomal antioxidant complex.

External resources
Website

Sponsored content

site-industries-cosmetiques A smiling woman with long hair stands in an open field. The text reads: "See you at in-cosmetics global, April 8-10 in Amsterdam, stand 11J41. Discover the Holistic Beauty Study with Cerebiome® for skin health." The Lallemand logo is visible in the bottom corner.

New publication with Cerebiome® for the intestine-brain-skin axis

Lallemand Health Solutions' innovative formula shows benefits for occasional stress, sleep quality and skin appearance.
site-industries-cosmetiques A woman with long brown hair and green eyes poses pensively against a colorful background of automobile drafts. She touches her face with one hand, revealing pink lips and pale skin, while the lighting accentuates her features.

VividEYE™

Brightens dark circles and reduces puffiness.

Related articles

Our last issue

Listen to us!

Newsletter

en_USEnglish